Authors
Loading...
Prospective study identifies biomarker differences in malignant IPMN versus non-malignant lesions, suggesting improved risk assessment.
Ferrara et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: